Company Haleon Pakistan Limited

HALEON

PK0112101016

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Generic Pharmaceuticals

End-of-day quote Pakistan S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
229.8 ^PKR	-0.28%		+6.64%	+35.95%

2023	Haleon Pakistan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Haleon Pakistan Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Haleon Pakistan Limited, formerly Glaxosmithkline Consumer Healthcare Pakistan Limited, is a Pakistan-based healthcare company. The Company's product portfolio consists of five categories, namely oral health, pain relief, respiratory health, digestive health and other, and vitamins, minerals and supplements (VMS). Its geographical segment consists of North America; Europe, Middle East & Africa (EMEA) and Latin America (LatAm), and Asia-Pacific (APAC). The Brands under Oral Health include Sensodyne, Parodontax, Polident, and Biotene. Its Vitamins, Minerals and Supplements offers a portfolio of brands, such as Centrum, a multivitamin and mineral brand; calcium supplements through its Caltrate brand, and vitamin C supplements through Emergen-C. The Brands under Respiratory consists of Otrivin, Theraflu, and Flonase. The Company's Pain Relief product includes Panadol, Voltaren and Advil brands. Its portfolio digestive health brands consists of Eno, Tums, and Fenistil.

Number of employees: 478

PKR in Million	2022	Weight	2023	Weight	Delta
Consumer Healthcare 100.0 %	27,507	100.0 %	31,610	100.0 %	+14.91%

PKR in Million	2022	Weight	2023	Weight	Delta
Pakistan 100.0 %	27,507	100.0 %	31,610	100.0 %	+14.91%

Managers	Title	Age	Since
Farhan Muhammad Haroon CEO	Chief Executive Officer	-	21-03-31
Dilawar Meghani DFI	Director of Finance/CFO	-	14-12-31
Mashal Mohammad IRC	Investor Relations Contact	-	20-05-30
Ensherah Khan HRO	Human Resources Officer	-	-
Salman Altaf SAM	Sales & Marketing	-	21-06-30
Syed Abrar Ali SAM	Sales & Marketing	-	20-12-06

Members of the board	Title	Age	Since
Ayesha Tanveer Aziz BRD	Director/Board Member	-	21-03-02
Syed Anwar Mahmood BRD	Director/Board Member	-	16-06-22
Farhan Muhammad Haroon CEO	Chief Executive Officer	-	21-03-31
Muhammad Zindah Moin Mohajir CHM	Chairman	-	18-04-25
Sumru Atalay BRD	Director/Board Member	-	-
Oussama Abbas BRD	Director/Board Member	-	20-08-25
Dilawar Meghani DFI	Director of Finance/CFO	-	14-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	117,054,508	16,626,740 ( 14.20 %)	0	14.20 %

Name	Equities	%	Valuation
GSK PLC 85.79 %	100,423,259	85.79 %	70 M ₨
National Investment Trust Ltd. 1.831 %	2,143,307	1.831 %	2 M ₨
MCB-Arif Habib Savings & Investments Ltd. (Invt Mgmt) 1.030 %	1,205,338	1.030 %	845 508 ₨
Al Meezan Investment Management Ltd. 0.2340 %	273,856	0.2340 %	192 102 ₨
NBP Fund Management Ltd. 0.0870 %	101,844	0.0870 %	71 441 ₨
Faysal Asset Management Ltd. 0.001709 %	2,000	0.001709 %	1 403 ₨
ABL Asset Management Co., Ltd. 0.000683 %	800	0.000683 %	561 ₨
UBL Fund Managers Ltd. 0.000633 %	741	0.000633 %	520 ₨

Haleon Pakistan Ltd.

Petaro Road Sandoz Nagar

76100, Jamshoro

http://www.pk-consumerhealthcare.gsk.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
HALEON PAKISTAN LIMITED	+35.95%	96.69M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.91%	43.54B
OTSUKA HOLDINGS CO., LTD.	+16.96%	21.74B
CIPLA LIMITED	+7.98%	13.02B
SANDOZ GROUP AG	+8.02%	13.53B
ZYDUS LIFESCIENCES LIMITED	+33.80%	11.28B
ONO PHARMACEUTICAL CO., LTD.	-11.05%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+7.71%	5.09B

Generic Pharmaceuticals